FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 3212435 · Received July 9, 2013

Report

Report Number
2124215-2013-09218
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
May 28, 2013
Report Date
May 29, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, NO RETURN OF PRODUCT IS INTENDED, THEREFORE, ANALYSIS CANNOT BE PERFORMED TO CONFIRM OR DENY THE REPORTED CLINICAL ALLEGATION.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A FOLLOW UP VISIT, INTERROGATION OF THIS CHRONIC RIGHT VENTRICULAR LEAD REVEALED AN ABRUPT HIGH OUT OF RANGE IMPEDANCE MEASUREMENT APPROXIMATELY TWO MONTHS EARLIER. A POSSIBLE LEAD FRACTURE WAS SUSPECTED. AS THE PATIENT WITH THIS LEAD IS PACEMAKER DEPENDENT WITH AN ESCAPE RHYTHM AND LONG PAUSES, A REVISION PROCEDURE WILL BE PERFORMED. DURING THE INTENDED REVISION, THIS LEAD WILL BE SURGICALLY ABANDONED AND REPLACED. NO ADVERSE PATIENT SYMPTOMS WERE EXPERIENCED AS A RESULT OF THIS ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
314321 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4457

Patients

Seq Age Sex Outcome Treatment
1